Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia

L H Castilla1, P Perrat, N J Martinez

  • 1Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, MA 01605, USA. lucio.castilla@umassmed.edu

Insights

Researchers identified genes cooperating with the CBFB-MYH11 fusion gene in acute myeloid leukemia (AML). This retroviral screen in mice revealed specific genetic alterations that synergize with CBFB-MYH11 to cause leukemia, advancing our understanding of AML pathogenesis.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Acute myeloid leukemia (AML) subtype M4 with eosinophilia involves a chromosome 16 inversion creating the CBFB-MYH11 fusion gene.
  • The CBFB-MYH11 fusion gene is essential but not sufficient for causing leukemia.

Purpose of the Study:

  • To identify genes that cooperate with CBFB-MYH11 in leukemogenesis.
  • To understand the genetic mechanisms driving AML development in the presence of the CBFB-MYH11 fusion.

Main Methods:

  • Utilized a retroviral genetic screen in Cbfb-MYH11 knock-in chimeric mice.
  • Administered retrovirus 4070A to neonatal mice, inducing AML development within 2-5 months.
  • Determined the chromosomal positions of 67 independent retroviral insertion sites (RISs) to identify cooperating genes.

Main Results:

  • Identified 54 candidate genes cooperating with CBFB-MYH11, with 90% of RISs located near a gene.
  • Six common insertion sites (CISs) were identified, including zinc finger transcription factors PLAG1 and PLAGL2, RUNX2, and MYB.
  • 18 of the 48 genes with single insertion sites coincided with known leukemia-associated RISs.

Conclusions:

  • This study presents the first retroviral genetic screen to identify cooperating genes for a fusion gene critical in human myeloid leukemia.
  • The findings highlight specific genes that, when altered, synergize with CBFB-MYH11 to drive leukemogenesis.
  • This research provides insights into the complex genetic landscape of AML and potential therapeutic targets.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...